Preclinical concept studies showing advantage of an inhaled anti-CTGF/CCN2 protein for pulmonary fibrosis treatment
Vanessa Neiens(German Center for Lung Research), Marina Pavlidou(Pieris Pharmaceuticals (United States)), Stefan Grüner(Pieris Pharmaceuticals (United States)), J. Peper-Gabriel(Pieris Pharmaceuticals (United States)), Oliver Eickelberg(Justus-Liebig-Universität Gießen), Kei W. Müller(Cobuilder (Norway)), Konrad Höetzenecker(Medical University of Vienna), Adriana Estrada‐Bernal(University of Colorado Denver), Gabriele Matschiner(Pieris Pharmaceuticals (United States)), Sandra Kerstan(Pieris Pharmaceuticals (United States)), Eva-Maria Hansbauer(Pieris Pharmaceuticals (United States)), Shane A. Olwill(Pieris Pharmaceuticals (United States)), Thomas J. Jaquin(Pieris Pharmaceuticals (United States)), Antonio Konitsiotis(Pieris Pharmaceuticals (United States)), Jonas Biehler(Cobuilder (Norway)), Joe A. Wrennall(University of North Carolina at Chapel Hill), Robert Tarran(University of North Carolina at Chapel Hill), Poornima Mahavadi(Justus-Liebig-Universität Gießen), Janette K. Burgess(The University of Sydney), Mark E. Snyder(University of Pittsburgh), Claudia Wurzenberger(Pieris Pharmaceuticals (United States)), Kentaro Noda(UPMC Health System), Theresia Mosebach(Pieris Pharmaceuticals (United States)), Karl-Robert Wichmann(Cobuilder (Norway)), Kristina Heinig(Ludwig-Maximilians-Universität München), Athanasios Fysikopoulos(Pieris Pharmaceuticals (United States)), Mary Fitzgerald(Pieris Pharmaceuticals (United States)), Marleen Richter(Pieris Pharmaceuticals (United States)), Andreas Günther(Justus-Liebig-Universität Gießen), Nicolas Schwenck(Pieris Pharmaceuticals (United States)), Cornelia Wurzenberger(Pieris Pharmaceuticals (United States)), Denis Bartoschek(Pieris Pharmaceuticals (United States)), Maximilian J. Grill(Cobuilder (Norway))
Cited by 13
Related Papers
WNT1-inducible signaling protein–1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis
|Journal of Clinical Investigation|2009|553
Functional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis
|PLoS ONE|2008|504
What are the respiratory effects of e-cigarettes?
|BMJ|2019|503
Phenotypes of organ involvement in sarcoidosis
|European Respiratory Journal|2018|245
Emphysema diagnosis using X-ray dark-field imaging at a laser-driven compact synchrotron light source
|Proceedings of the National Academy of Sciences|2012|190